Corinna Schölch

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder et al. · Nature Metabolism · 2024 · 229 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

Natalie R. van Zuydam, Emma Ahlqvist, Niina Sandholm et al. · Diabetes · 2018 · 197 citations · Full text

Medicine, Endocrinology, Molecular Genetics +17

The effect of leptin treatment on the development of obesity in overfed suckling Wistar rats

Inger Kappel Schmidt, Anne Fritz, Corinna Schölch et al. · International Journal of Obesity · 2001 · 90 citations

Medicine, Endocrinology, Physiology +14

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist <scp>BI</scp> 456906

Arvid Jungnik, Jorge Arrubla, Leona Plum‐Mörschel et al. · Diabetes Obesity and Metabolism · 2022 · 60 citations · Full text

Pharmacy, Endocrinology, Pharmacology +17

Safety, pharmacokinetics and pharmacodynamics of <scp>BI</scp> 135585, a selective 11β‐hydroxysteroid dehydrogenase‐1 ( <scp>HSD1</scp> ) inhibitor in humans: liver and adipose tissue 11β‐ <scp>HSD1</scp> inhibition after acute and multiple administrations over 2 weeks

S Freude, Tim Heise, Hans J. Woerle et al. · Diabetes Obesity and Metabolism · 2016 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +13